P-glycoprotein attenuating effect of human intestinal fluid

被引:29
作者
Deferme, S
Tack, J
Lammert, F
Augustijns, P
机构
[1] Katholieke Univ Leuven, Lab Pharmacotechnol & Biopharm, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Ctr Gastroenterol Res, B-3000 Louvain, Belgium
[3] Univ Aachen, Univ Hosp, Dept Med 3, D-52057 Aachen, Germany
关键词
P-glycoprotein; bile salts; intestinal fluid; drug absorption; efflux;
D O I
10.1023/A:1023891320858
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To evaluate the effect of human intestinal fluid (HIF) on P-glycoprotein (P-gp)-mediated efflux. Methods. HIF was obtained from eight healthy volunteers by duodenal aspiration. HIF was applied at different concentrations (0-75%) to the apical compartment of the Caco-2 system. Cyclosporin A (CsA) was used as a model compound for P-gp mediated efflux. Results. When the bidirectional transport of CsA across Caco-2 monolayers was assessed, a significant polarity in transport could be observed, the absorptive transport being much lower than the secretory transport. Inclusion of HIF resulted in a moderate increase of the absorptive transport, as well as a significant concentration dependent decrease of the secretory transport, without compromising the integrity of the monolayer. Interestingly, a possible gender difference could be detected as inclusion of HIF obtained from female subjects resulted in a decreased absorptive transport of CsA, whereas inclusion of HIF obtained from male subjects resulted in an increased absorptive transport. The P-gp modulating effect of HIF is not caused by a lack of glucose as an energy source for the efflux mechanism when high concentrations of HIF were present in the buffer used. Conclusions. The results of this study indicate that the contribution of P-gp efflux carriers may be overestimated when using salt buffer solutions as transport media. Additionally, it can be concluded that ( presently unidentified) components of HIF may attenuate the P-gp mediated intestinal efflux. The clinical significance of this modulating effect remains to be investigated.
引用
收藏
页码:900 / 903
页数:4
相关论文
共 16 条
  • [1] EVIDENCE FOR A POLARIZED EFFLUX SYSTEM IN CACO-2 CELLS CAPABLE OF MODULATING CYCLOSPORINE-A TRANSPORT
    AUGUSTIJNS, PF
    BRADSHAW, TP
    GAN, LSL
    HENDREN, RW
    THAKKER, DR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) : 360 - 365
  • [2] IS DUODENAL BILE REPRESENTATIVE OF GALLBLADDER BILE - A COMPARATIVE-STUDY
    CHOUDHURI, G
    AGARWAL, DK
    SARASWAT, VA
    NEGI, TS
    SAXENA, R
    KAPOOR, VK
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 (10) : 920 - 923
  • [3] Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms
    Dressman, JB
    Amidon, GL
    Reppas, C
    Shah, VP
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (01) : 11 - 22
  • [4] MEASUREMENT OF GASTROINTESTINAL PH PROFILES IN NORMAL AMBULANT HUMAN-SUBJECTS
    EVANS, DF
    PYE, G
    BRAMLEY, R
    CLARK, AG
    DYSON, TJ
    HARDCASTLE, JD
    [J]. GUT, 1988, 29 (08) : 1035 - 1041
  • [5] Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs
    Galia, E
    Nicolaides, E
    Hörter, D
    Löbenberg, R
    Reppas, C
    Dressman, JB
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (05) : 698 - 705
  • [6] Gray VA, 1996, PHARMACOPEIAL FORUM, V22, P1943
  • [7] GURANTZ D, 1981, J LIPID RES, V22, P373
  • [8] Simulated intestinal fluid as transport medium in the Caco-2 cell culture model
    Ingels, F
    Deferme, S
    Destexhe, E
    Oth, M
    Van den Mooter, G
    Augustijns, P
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 232 (1-2) : 183 - 192
  • [9] COMPARISON OF GALL-BLADDER BILE AND ENDOSCOPICALLY OBTAINED DUODENAL BILE
    JANOWITZ, P
    SWOBODNIK, W
    WECHSLER, JG
    ZOLLER, A
    KUHN, K
    DITSCHUNEIT, H
    [J]. GUT, 1990, 31 (12) : 1407 - 1410
  • [10] Characterization of fluids from the stomach and proximal jejunum in men and women
    Lindahl, A
    Ungell, AL
    Knutson, L
    Lennernas, H
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (04) : 497 - 502